Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Poziotinib Found Safe And Effective In HER2 Exon 20 Insertion NSCLC Patients Nov 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Pathological Analysis of Nivolumab Combo in Resectable NSCLC Nov 20, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Osimertinib Shows Favorable Outcomes In Final OS Analysis Of NSCLC Patients Nov 17, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) ATZ-TBP Shows Favorable Benefit-risk Profile In Extensive-Stage SCLC Nov 17, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Proves Effective In Advanced NSCLC Patients With METex 14 Mutations Nov 16, 2023
Lung Cancer,SCLC (Small Cell Lung Cancer) Cabozantinib Shows Improved Outcomes Vs. Placebo For Advanced NET Nov 16, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tepotinib + Osimertinib in EGFR-Mutant NSCLC With MET Amplification After 1L Osimertinib Nov 15, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),SCLC (Small Cell Lung Cancer) Multisite SBRT + Ipilimumab + Nivolumab Is Well-Tolerated In First Line Metastatic NSCLC Nov 14, 2023
